Ken Griffin Atri Cure, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,900 shares of ATRC stock, worth $229,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,900
Previous 12,300
43.9%
Holding current value
$229,494
Previous $375,000
40.8%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding ATRC
# of Institutions
237Shares Held
51.9MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$157 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$154 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$122 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$99.8 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$81 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.54B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...